Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
McKinsey
Daiichi Sankyo
Cantor Fitzgerald
Chubb
Medtronic
Moodys
Julphar

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020219

« Back to Dashboard

NDA 020219 describes LIVOSTIN, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the LIVOSTIN profile page.

The generic ingredient in LIVOSTIN is levocabastine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levocabastine hydrochloride profile page.
Summary for 020219
Tradename:LIVOSTIN
Applicant:Novartis
Ingredient:levocabastine hydrochloride
Patents:0
Therapeutic Class:Ophthalmic Agents

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;OPHTHALMICStrengthEQ 0.05% BASE
Approval Date:Nov 10, 1993TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Queensland Health
Deloitte
Chinese Patent Office
Colorcon
Moodys
AstraZeneca
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.